Rock Springs Capital Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-134,028
| Closed | -$44.2K | – | 105 |
|
|
2025
Q4 | $44.2K | Hold |
134,028
| – | – | ﹤0.01% | 99 |
|
|
2025
Q3 | $27.1K | Hold |
134,028
| – | – | ﹤0.01% | 92 |
|
|
2025
Q2 | $36.2K | Hold |
134,028
| – | – | ﹤0.01% | 93 |
|
|
2025
Q1 | $32K | Hold |
134,028
| – | – | ﹤0.01% | 96 |
|
|
2024
Q4 | $30.8K | Hold |
134,028
| – | – | ﹤0.01% | 107 |
|
|
2024
Q3 | $13.1K | Hold |
134,028
| – | – | ﹤0.01% | 109 |
|
|
2024
Q2 | $21.4K | Hold |
134,028
| – | – | ﹤0.01% | 112 |
|
|
2024
Q1 | $40.5K | Hold |
134,028
| – | – | ﹤0.01% | 114 |
|
|
2023
Q4 | $8.04K | Hold |
134,028
| – | – | ﹤0.01% | 104 |
|
|
2023
Q3 | $13.4K | Hold |
134,028
| – | – | ﹤0.01% | 120 |
|
|
2023
Q2 | $22.2K | Hold |
134,028
| – | – | ﹤0.01% | 123 |
|
|
2023
Q1 | $16.1K | Hold |
134,028
| – | – | ﹤0.01% | 121 |
|
|
2022
Q4 | $19.4K | Hold |
134,028
| – | – | ﹤0.01% | 120 |
|
|
2022
Q3 | $27K | Hold |
134,028
| – | – | ﹤0.01% | 128 |
|
|
2022
Q2 | $38K | Hold |
134,028
| – | – | ﹤0.01% | 131 |
|
|
2022
Q1 | $108K | Hold |
134,028
| – | – | ﹤0.01% | 135 |
|
|
2021
Q4 | $253K | Hold |
134,028
| – | – | 0.01% | 136 |
|
|
2021
Q3 | $343K | Hold |
134,028
| – | – | 0.01% | 153 |
|
|
2021
Q2 | $348K | Hold |
134,028
| – | – | 0.01% | 155 |
|
|
2021
Q1 | $358K | Buy |
+134,028
| New | +$388K | 0.01% | 151 |
|
Rock Springs Capital Management's NUVB.WS Position: Q1 2026 in Review
Rock Springs Capital Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 134,028 shares — an estimated $44.2K sold.
Rock Springs Capital Management first reported a position in NUVB.WS in Q1 2021 and held it in 20 quarters. The position peaked at $358K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- Rock Springs Capital Management reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- Rock Springs Capital Management sold 134,028 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $44.2K.
- Rock Springs Capital Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 20 quarters.
- Rock Springs Capital Management's Nuvation Bio Inc Warrants position peaked at $358K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on Rock Springs Capital Management's 13F filing for Q1 2026, filed 15 May 2026.